» Articles » PMID: 21863512

[Current Status of Multimodal Therapy for Colorectal Liver Metastases]

Overview
Journal Zentralbl Chir
Publisher Thieme
Specialty General Surgery
Date 2011 Aug 25
PMID 21863512
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Surgical resection is the only chance of cure for patients with colorectal liver metastases und significantly improves patient survival. The percentage of patients who can undergo curative resection as well as the survival after liver resection can be increased by using modern multimodal treatment algorithms. This has been achieved by not only innovations in pre- and postoperative chemotherapy but also by new surgical and interventional techniques and last but not least by individualisation of chemotherapeutic regimens. Due to the high number of new treatment modalities, a generally accepted treatment algorithm cannot be provided so far for all subgroups of the inhomogeneous group of patients with colorectal liver metastases. In the present review the current status of multimodal therapy is outlined and the pending questions mentioned.

Citing Articles

Intraoperative placement of external biliary drains for prevention and treatment of bile leaks after extended liver resection without bilioenteric anastomosis.

Strucker B, Stockmann M, Denecke T, Neuhaus P, Seehofer D World J Surg. 2013; 37(11):2629-34.

PMID: 23892726 DOI: 10.1007/s00268-013-2161-z.


Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases.

Sperling J, Schafer T, Benz-Weisser A, Ziemann C, Scheuer C, Kollmar O Int J Colorectal Dis. 2012; 28(4):555-62.

PMID: 23242249 PMC: 3639362. DOI: 10.1007/s00384-012-1617-1.